Tryptamine Therapeutics (AU:TYP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tryptamine Therapeutics Limited (ASX: TYP) has requested a trading halt on its shares pending a significant announcement related to a capital raising program. The halt will remain until either the announcement is made or normal trading resumes on October 30, 2024. Investors are keenly awaiting further details which could impact the company’s stock performance.
For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.